Herbal hope: new combo therapy targets advanced pancreatic cancer

NCT ID NCT05840341

Completed Disease control Sponsor: Fudan University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether adding a Chinese herbal formula (QingyiHuaji) to standard chemotherapy helps people with stage IV pancreatic cancer live longer. About 305 adults with advanced pancreatic cancer were randomly assigned to receive either the herbal formula plus chemo or a placebo plus chemo. The main goal was to see if the combination improved overall survival, with secondary goals of slowing cancer growth and improving quality of life.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PANCREATIC NEOPLASMS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

pancreatic ductal adenocarcinoma pancreatic neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PANCREATIC NEOPLASMS

Contacts and locations

Locations

Affiliated Hospital of Nanjing University of Traditional Chinese Medicine

Nanjing, Jiangsu, 210000, China
Cancer Hospital Chinese Academy of Medical Sciences

Beijing, Beijing Municipality, 100000, China
Fudan University Shanghai Cancer Center

Shanghai, Shanghai Municipality, 200000, China
Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

Shanghai, Shanghai Municipality, 200000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.